|
SP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.389000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.163000E-03 |
| Normal-vs-Stage2 |
2.826000E-04 |
| Normal-vs-Stage3 |
2.625600E-04 |
| Normal-vs-Stage4 |
2.723600E-03 |
| Stage1-vs-Stage2 |
1.052640E-01 |
| Stage1-vs-Stage3 |
1.665050E-01 |
| Stage1-vs-Stage4 |
4.660600E-01 |
| Stage2-vs-Stage3 |
5.632000E-01 |
| Stage2-vs-Stage4 |
4.165400E-01 |
| Stage3-vs-Stage4 |
7.538800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.218700E-04 |
| Normal-vs-AfricanAmerican |
5.010200E-02 |
| Normal-vs-Asian |
1.726300E-02 |
| Caucasian-vs-AfricanAmerican |
9.327000E-01 |
| Caucasian-vs-Asian |
8.021200E-01 |
| AfricanAmerican-vs-Asian |
9.286600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.462200E-03 |
| Normal-vs-Female |
3.776900E-04 |
| Male-vs-Female |
6.805600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.102300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.555430E-04 |
| Normal-vs-Age(61-80Yrs) |
8.06330000000521E-05 |
| Normal-vs-Age(81-100Yrs) |
2.009500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.825500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.033700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.634100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.649800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.231600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.586200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.536200E-01 |
| Classical-VS-Follicular |
1.9491899999946E-05 |
| Classical-VS-Other |
4.710200E-01 |
| Classical-VS-Normal |
1.644110E-02 |
| Tall-VS-Follicular |
1.368600E-01 |
| Tall-VS-Other |
9.010400E-01 |
| Tall-VS-Normal |
1.344440E-02 |
| Follicular-VS-Other |
4.929000E-01 |
| Follicular-VS-Normal |
9.7919999997309E-07 |
| Other-VS-Normal |
1.269030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85560000000229E-05 |
| Normal-vs-N1 |
3.260100E-03 |
| N0-vs-N1 |
5.627800E-01 |
|
|
